Lin Shao-Lee Insider Trades & Stock Holdings

Chief Executive Officer · Cue Biopharma, Inc. · Latest filing Oct 12, 2026

Lin Shao-Lee, Chief Executive Officer at Cue Biopharma, Inc. has 1 Form 4 trade on file since Oct 12, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($305.49K), net -$305.49K. Latest filing: disposed of 11.09K shares of $CUE on Oct 12, 2026 at $27.55.

Trades on file

1

Open-market bought

$0

Open-market sold

$305.49K

Net open-market

-$305.49K

Latest filing

Oct 12, 2026

All insider trades by Lin Shao-Lee

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 12, 2026	$CUE	Sell (Open-market sale)	11.09K	$27.55	$305.49K						Chief Executive Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Lin Shao-Lee traded

• $CUE

Frequently asked questions

Has Lin Shao-Lee been buying or selling stock?

Lin Shao-Lee has 0 open-market purchases and 1 open-market sale on file, net -$305.49K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Lin Shao-Lee's latest insider trade?

disposed of 11.09K shares of $CUE on Oct 12, 2026 at $27.55.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.